Progression of Alzheimer disease in Europe: Data from the European ICTUS study

Current Alzheimer Research

Volumn 9, Issue 8, 2012, Pages 902-912

  Vellas, B ^a,d   Hausner, L ^a,b   Frolich L ^b,d   Cantet, C ^a   Gardette, V ^a   Reynish, E ^b,c,d   Gillette, S ^a   Aguera Morales E ^d,e   Auriacombe, S ^d,f   Boada, M ^d,g   Bullock, R ^d,h   Byrne, J ^d,i   Camus, V ^d,j   Cherubini, A ^d,k   Eriksdotter Jonhagen M ^d,l   Frisoni, G B ^d,m   Hasselbalch, S ^d,n   Jones, R W ^d,o   Martinez Lage, P ^d,p   Rikkert, M O ^d,q   Tsolaki, M ^d,r   Ousset, P J ^a,d   Pasquier, F ^d,s   Ribera Casado, J M ^d,t   Rigaud, A S ^d,u   Robert, P ^d,v   Rodriguez, G ^d,w   Salmon, E ^d,x   Salva, A ^d,y   Scheltens, P ^d,z   Schneider, A ^d,aa   Sinclair, A ^d,ab   Spiru, L ^d,ac   Touchon, J ^d,ad   Zekry, D ^d,ae   Winblad, B ^d,af   Andrieu, S ^a,d   more..

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ROYAL EDINBURGH HOSPITAL   (United Kingdom)

^d Royal Edinburgh Hospital ^*  (United Kingdom)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f INSERM   (France)

^g Fundacio ACE   (Spain)

^h Victoria Centre   (United Kingdom)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

^j UNIVERSITY HOSPITAL OF TOURS   (France)

^k UNIVERSITY OF PERUGIA   (Italy)

^l KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^m IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

ⁿ UNIVERSITY OF COPENHAGEN   (Denmark)

^o ROYAL UNITED HOSPITAL   (United Kingdom)

^p UNIVERSITY CLINIC OF NAVARRA   (Spain)

^q RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^r ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^s LILLE UNIVERSITY HOSPITAL   (France)

^t HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^u Paris Descartes University   (France)

^v UNIVERSITY HOSPITAL OF NICE   (France)

^w UNIVERSITY OF GENOA   (Italy)

^x UNIVERSITY OF LIÈGE   (Belgium)

^y UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^z VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^aa UNIVERSITY OF GÖTTINGEN   (Germany)

^ab UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

^ac CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^ad GUI DE CHAULIAC HOSPITAL   (France)

^ae Hopital de Geriatrie   (Switzerland)

^af KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

Alzheimer's disease; Caregiver burden, hospital admission; Clinical course; Cognitive; Cohort study; Dementia; Europe; Functional; Geographical variation; NPI

Indexed keywords

CHOLINESTERASE INHIBITOR; MEMANTINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; CAREGIVER BURDEN; COGNITION; DAILY LIFE ACTIVITY; DISEASE COURSE; EUROPE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; DISEASE PROGRESSION; EUROPE; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; SOCIOECONOMIC FACTORS;

EID: 84867732715     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720512803251066     Document Type: Article

References (51)

1. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafstrom M, Holmen K, Ericsson K, Backman L, Ahlbom A, Winblad B. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 41: 1886-1892 (1991).
2. Friedland RP. Epidemiology, education, and the ecology of Alzheimer's disease. Neurology 43(2): 246-9 (1993).
3. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS): Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357: 169-175 (2001).
4. Galasko D, Edland SD, Morris JC, Clark C, Mohs R, Koss E. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years. Neurology 45(8): 1451-5 (1995).
5. Hanyu H, Sato T, Hirao K, Kanetaka H, Sakurai H, Iwamoto T. Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease. Eur J Neurol 16: 212-217 (2009).
6. Bruandet A, Richard F, Bombois S, Maurage CA, Deramecourt V, et al. Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry 80: 133-139 (2009).
7. Bidzan L, Pachalska M, Grochmal-Bach B, Bidzan M, Jastrzebowska G. Behavioral and psychological symptoms and the progression of dementia of the Alzheimer type in nursing home residents. Med Sci Monit 14: CR559-567 (2008).
8. Stern Y. Cognitive reserve. Neuropsychologia 47(10): 2015-2028 (2009).
9. Scarmeas N, Stern Y. Cognitive Reserve: Implications for Diagnosis and Prevention of Alzheimer's Disease. Curr Neurol Neurosci Rep 4(5): 374-380 (2004).
10. Napoles AM, Chadiha L, Eversley R, Moreno-John G. Developing culturally sensitive dementia caregiver interventions: are we there yet? Am J Alzheimers Dis Other Demen 25(5): 389-406 (2010).
11. Torti FM Jr, Gwyther LP, Reed SD, Friedman JY, Schulman KA. A multinational review of recent trends and reports in dementia caregiver burden. Alzheimer Dis Assoc Disord 18(2): 99-109 (2004).
12. Pariente A, Helmer C, Merliere Y, Moore N, Fourrier-Reglat A, Dartigues JF. Prevalence of cholinesterase inhibitors in subjects with dementia in Europe. Pharmacoepidemiol Drug Saf 17: 655-60 (2008).
13. Hogan DB, Bailey P, Carswell A, Clarke B, Cohen C, Forbes D, et al. Management of mild to moderate Alzheimer's disease and dementia. Alzheimers Dement 3(4): 355-84 (2007).
14. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, et al. EFNS. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 14(1): e1-26 (2007).
15. Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, Pratt RD; "312" Study Group. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology 57(3): 481-8 (2001).
16. Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wimo A, et al. Donepezil Nordic Study Group. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 57(3): 489-95 (2001).
17. Gauthier S, Cummings J, Ballard C, Brodaty H, Grossbery G, Robert P. Management of behavioral problems in Alzheimer's disease. Int Psychogeriatr 22: 346-372 (2010).
18. Olazarán J, Reisberg B, Clare L, Cruz I, Pena-Casanova J, et al. Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy. Dement Geriatr Cogn Disord 30(2): 161-78 (2010).
19. Bank AL, Argüelles S, Rubert M, Eisdorfer C, Czaja SJ. The value of telephone support groups among ethnically diverse caregivers of persons with dementia. Gerontologist 46(1): 134-8 (2006).
20. Rikkert MG, Lauque S, Frölich L, Vellas B, Dekkers W. The practice of obtaining approval from medical research ethics committees: a comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer's dementia. Eur J Neurol 12(3): 212-7 (2005).
21. Reynish E, Cortes F, Andrieu S, Cantet C, Olde Rikkert M, Melis R, et al. ICTUS Study Group. The ICTUS Study: A Prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Neuroepidemiology 29(1-2): 29-38 (2007).
22. World Population Prospects. The 2004 Revision, CD-ROM Edition (United Nations publication, Basic Dataset, Sales No. E.05. XIII.10; Comprehensive Dataset, Sales No. E.05. XIII.11; Extended Dataset, Sales No. E.05. XIII.12). page xiii (2004).
23. Wimo A, Winblad B, Jönsson L. The worldwide societal costs of dementia: Estimates for 2009. Alzheimers Dement 6(2): 98-103 (2010).
24. Hausner L, Frölich L, Gardette V, et al. On Behalf Of The Ictus-Eadc Study Group. Regional Variation on the Presentation of Alzheimer's Disease Patients in Memory Clinics within Europe: Data from the ICTUS Study. J Alzheimers Dis 21(1): 155-65 (2010).
25. Bolin K, Lindgren B, Lundborg P. Informal and formal care among single-living elderly in Europe. Health Econ 17: 393-409 (2008).
26. Kiejna A, Frydecka D, Adamowski T, Bickel H, Reynish E, Prince M, Caracciolo B, Fratiglioni L, Georges J. Epidemiological studies of cognitive impairment and dementia across Eastern and Middle European countries (epidemiology of dementia in Eastern and Middle European Countries). Int J Geriatr Psychiatry 26(2): 111-7. doi: 10.1002/gps.2511 (2011).
27. Jönsson L, Wimo A. The cost of dementia in Europe: a review of the evidence, and methodological considerations. Pharmacoeconomics 27: 391-403 (2009).
28. Mohs RC, Schmeidler J, Aryan M. Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer's disease. Statistics Med 19: 1401-1409 (2000).
29. Milliken JK, Edland SD. Mixed effect models of longitudinal Alzheimer's disease data: a cautionary note. Statistics Med 19: 1617-1629 (2000).
30. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, van Belle G, Fillenbaum G, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 43: 2457-2465 (1993).
31. Stern RG, Mohs RC, Davidson M. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 151: 390-396 (1994).
32. Lopez OL, Becker JT, Wisniewski S. Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry 72: 310-14 (2002).
33. Lopez OL, Becker JT, Saxton J, et al. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition. J Am Geriatr Soc 53: 83-7 (2005).
34. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev (1): CD005593 (2006).
35. Sink KM, Covinsky KE, Barnes DE, Newcomer RJ, Yaffe K Caregiver characteristics are associated with neuropsychiatric symptoms of dementia. J Am Geriatr Soc 54: 796-803 (2006).
36. Carpenter GI. Aging in the United Kingdom and Europe-a snapshot of the future? J Am Geriatr Soc 53 (suppl 9): 310-313 (2005).
37. Zunzunegui MV, Beland F, Llácer A, Keller I. Family, religion, and depressive symptoms in caregivers of disabled elderly. J Epidemiol Community Health J Epidemiol 53(6): 364-9 (1999).
38. Navaie-Waliser M, Feldman PH, Gould DA, Levine C, Kuerbis AN, Donelan K. The experiences and challenges of informal caregivers: common themes and differences among whites, blacks, and hispanics. Gerontologist 41(6): 733-41 (2001).
39. Germain S, Adam S, Olivier C, Cash H, Ousset PJ, Andrieu S, Vellas B, Meulemans T, Reynish E, Salmon E; ICTUS-EADC Network. Does cognitive impairment influence burden in caregivers of patients with Alzheimer's disease? J Alzheimers Dis 17(1): 105-14 (2009).
40. Coen RF, Swanwick GR, O'Boyle CA, Coakley D. Behaviour disturbance and other predictors of carer burden in Alzheimer's disease. Int J Geriatr Psychiatry 12: 331-336 (1997).
41. Razani J, Kakos B, Orieta-Barbalace C, Wong JT, Casas R, Lu P, Alessi C, Josephson K. Predicting caregiver burden from daily functional abilities of patients with mild dementia. J Am Geriatr Soc 55: 1415-1420 (2007).
42. Welmerink DB, Longstreth WT Jr, Lyles MF, Fitzpatrick AL. Cognition and the Risk of Hospital admission for Serious Falls in the Elderly: Results From the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci 65(11): 1242-9 (2010).
43. Rudolph JL, Zanin NM, Jones RN, Marcantonio ER, Fong TG, Yang FM, et al. Hospital admission in Community-Dwelling Persons with Alzheimer's Disease: Frequency and Causes. J Am Geriatr Soc 58(8): 1542-8 (2010).
44. Behl P, Lanctôt KL, Streiner DL, Black SE. The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort. Int Psychogeriatr 20(6): 1141-59 (2008).
45. Coley N, Gardette V, Toulza O, Gillette-Guyonnet S, Cantet C, Nourhashemi F, et al. Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL. FR study. Neuroepidemiology 31(2): 69-79 (2008).
46. Hurst SA, Forde R, Reiter-Theil S, Slowther AM, Perrier A, et al. Physicians' views on resource availability and equity in four European health care systems. BMC Health Serv Res 7: 137 (2007).
47. Shyu YI, Kuo LM, Chen MC, Chen ST. A clinical trial of an individualised intervention programme for family caregivers of older stroke victims in Taiwan. J Clin Nurs 19(11-12): 1675-85 (2010).
48. Andrieu S, Balardy L, Gillette-Guyonnet S, Bocquet H, Cantet C, Albarede JL, et al. Burden experienced by informal caregivers assisting Alzheimer's patients in the REAL. FR study (in French). Rev Méd Interne 24(suppl 3): 351-359 (2003).
49. Gardette V, Coley N, Toulza O, Andrieu S. Attrition in geriatric research: how important is it and how should it be dealt with? J Nutr Health Aging 11: 265-271 (2007).
50. Koss E, Peterson B, Fillenbaum GG. Determinants of attrition in a natural history study of Alzheimer disease. Alzheimer Dis Assoc Disord 13: 209-215 (1999).
51. Starkstein SE, Jorge R, Mizrahi R, Robinson RG. A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 77: 8-11 (2006).